Kamada Ltd (KMDA) reports a 13% revenue increase and unveils plans for biosimilar launches and plasma center expansions.

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

M, +43% v. 2023; 4Q 2024 revenues of $77M, +31% v. 4Q 20232024 net income of $28M; Non-GAAP net income of $68M 4Q 2024 net ...

Q4 2024 Earnings Call Transcript March 5, 2025 Kamada Ltd. beats earnings expectations. Reported EPS is $0.07, expectations ...

Record Year with Total 2024 Revenuesof $161.0Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up ...

Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full ...

Read here for 5 dividend stocks that offer a rare combination of high yields, wide moats, strong balance sheets, and growing ...

Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET ...

In a loss update ahead of its Q4 and full year 2024 earnings, specialty insurer Fidelis Insurance Holdings Limited has ...

Former soccer leaders Sepp Blatter and Michel Platini are back in a Swiss court as their new trial on fraud, forgery and ...

Aviation litigation stemming from the Russia-Ukraine conflict is having an impact on the profits of Bermudian-based global ...